Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,670 | -12,748 | -10,121 | -5,478 | -1,474 |
| Other Working Capital | -155 | 141 | -226 | 1,167 | -317 |
| Other Operating Activity | 949 | 7,593 | 6,833 | 3,435 | 1,244 |
| Operating Cash Flow | $-1,876 | $-5,014 | $-3,514 | $-877 | $-547 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 14,797 | 14,797 | 14,797 | 0 |
| Financing Cash Flow | $N/A | $14,797 | $14,797 | $14,797 | $N/A |
| Beginning Cash Position | 12,959 | 3,175 | 3,175 | 3,175 | 3,175 |
| End Cash Position | 11,083 | 12,959 | 14,459 | 17,096 | 2,628 |
| Net Cash Flow | $-1,876 | $9,783 | $11,284 | $13,920 | $-547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,876 | -5,014 | -3,514 | -877 | -547 |
| Free Cash Flow | -1,876 | -5,014 | -3,514 | -877 | -547 |